These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 18272636)
1. Approach to primary care follow-up of patients with prostate cancer. Wilkinson AN; Brundage MD; Siemens R Can Fam Physician; 2008 Feb; 54(2):204-10. PubMed ID: 18272636 [TBL] [Abstract][Full Text] [Related]
2. Prostate cancer screening practices in a large, integrated health system: 2007-2014. Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034 [TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen tests and prostate cancer screening: an update for primary care physicians. Kell JS Can J Urol; 2010 Feb; 17 Suppl 1():18-25. PubMed ID: 20170597 [TBL] [Abstract][Full Text] [Related]
4. [Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians]. Giménez N; Filella X; Gavagnach M; Allué JA; Pedrazas D; Ferrer F; Semergen; 2018 Sep; 44(6):409-419. PubMed ID: 29574008 [TBL] [Abstract][Full Text] [Related]
5. Prostate cancer and PSA screening. Mameghan H Aust Fam Physician; 1999 Aug; 28(8):777-81. PubMed ID: 10495525 [TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer. Bunting PS; Goel V; Williams JI; Iscoe NA CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349 [TBL] [Abstract][Full Text] [Related]
7. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Fowler FJ; Bin L; Collins MM; Roberts RG; Oesterling JE; Wasson JH; Barry MJ Am J Med; 1998 Jun; 104(6):526-32. PubMed ID: 9674714 [TBL] [Abstract][Full Text] [Related]
8. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. Hayes JH; Barry MJ JAMA; 2014 Mar; 311(11):1143-9. PubMed ID: 24643604 [TBL] [Abstract][Full Text] [Related]
9. [Utilization of screening and treatment of prostate cancer in 2011]. Tombal B Bull Mem Acad R Med Belg; 2011; 166(3-4):170-6; discussion 177. PubMed ID: 22375496 [TBL] [Abstract][Full Text] [Related]
10. Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy. Coetzee LJ; Hars V; Paulson DF Urology; 1996 Feb; 47(2):232-5. PubMed ID: 8607240 [TBL] [Abstract][Full Text] [Related]
11. PSA and the family physician. Barkin J Can J Urol; 2011 Apr; 18 Suppl():20-3. PubMed ID: 21501547 [TBL] [Abstract][Full Text] [Related]
12. [Attitude of primary care physicians to early detection of prostatic cancer through prostate-specific antigen]. Oller Colom M; Jiménez Navarrete S; Hidalgo García A; Calvo Rosa E; Pérez Herrera MM; Castellanos Duarte RM; Simón Muela CI; Asens Mampel N; Duaso Allué I; Gascón Gazulla S Aten Primaria; 2000 Sep; 26(5):323-6. PubMed ID: 11100603 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer. Candas B; Cusan L; Gomez JL; Diamond P; Suburu RE; Lévesque J; Brousseau G; Bélanger A; Labrie F Prostate; 2000 Sep; 45(1):19-35. PubMed ID: 10960839 [TBL] [Abstract][Full Text] [Related]
15. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017 [TBL] [Abstract][Full Text] [Related]
16. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians. Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P; Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643 [TBL] [Abstract][Full Text] [Related]
17. Factors influencing use of the prostate-specific antigen screening test in primary care. Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432 [TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen kinetics in localized and advanced prostate cancer. Fitzpatrick JM; Banu E; Oudard S BJU Int; 2009 Mar; 103(5):578-87. PubMed ID: 19210674 [TBL] [Abstract][Full Text] [Related]
19. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer. Hayat Roshanai A; Nordin K; Berglund G Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929 [TBL] [Abstract][Full Text] [Related]
20. PSA implications and medical management of prostate cancer for the primary care physician. Rehsia S; Shayegan B Can J Urol; 2012 Oct; 19 Suppl 1():28-35. PubMed ID: 23089345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]